Eiger BioPharmaceuticals, Inc. 3 SEC Filings

Filed On	Filing
30 Oct 2023	Form 3: Kayne Richard A, 10% owner Holds 1,667,100 shares of Common Stock
30 Oct 2023	Form 3: Kawas Leen, 10% owner Holds 1,667,100 shares of Common Stock
05 Sep 2023	Form 3: Choong Ingrid, Chief Business Officer Holds 31,100 shares of Common Stock
14 Apr 2023	Form 3: Vollins James, General Counsel No securities owned
14 Apr 2023	Form 3: Kachioff William G, CFO No securities owned
19 Jul 2022	Form 3: Kelly-Croswell Lisa, Director No securities owned
01 Oct 2021	Form 3: Atkisson Erik, GC & Chief Compliance Officer No securities owned
23 Apr 2021	Form 3: Sablich Kim, Director No securities owned
30 May 2019	Form 3: Sachdev Amit, Director No securities owned
25 Mar 2019	Form 3: Patton Stephana Eilene, See Remarks Holds 3,000 shares of Common Stock
09 Jan 2019	Form 3: Murray Christine, Director No securities owned
27 Dec 2018	Form 3: Ryali Sriram, Chief Financial Officer No securities owned
25 Oct 2018	Form 3: Ra Capital MANAGEMENT, Llc, 10% owner and 2 others Holds 2,415,458 shares of Common Stock
09 Jan 2018	Form 3: Mayer Eldon C. Iii, Director No securities owned
18 Sep 2017	Form 3: Loh Evan, Director No securities owned
20 Jun 2017	Form 3: Apelian David, Director No securities owned
31 Mar 2016	Form 3: Kjellson Nina S, Director Holds 1,599,593 shares of Common Stock
31 Mar 2016	Form 3: Interwest Partners X Lp, 10% owner and 8 others Holds 1,599,593 shares of Common Stock
28 Mar 2016	Form 3: Cory David A, Director Holds 56,889 shares of Common Stock
28 Mar 2016	Form 3: Vivo Ventures VI, Llc, 10% owner and 2 others Holds 1,587,960 shares of Common Stock

Comments